On August 26, 2015, an objection to the motion for authority to obtain debtor-in-possession financing was filed in the bankruptcy case of Response Genetics, Inc. (f/d/b/a Bio Type, Inc.) and its affiliates.
The filing was assigned docket number 67 and is described on the court’s official docket as follows:
Objection to Debtor’s Motion for Entry of Interim and Final Orders (1) Authorizing the Debtor to Obtain Postpetition Financing on an Interim Basis, Granting Senior Postpetition Security Interests and According Superpriority Administrative Expense Status Pursuant to Section 364(c) and 364(d) of the Bankruptcy Code, (2) Authorizing the Use of Cash Collateral, (3) Granting Adequate Protection, (4) Modifying the Automatic Stay, and (5) Granting Related Relief (related document(s)) Filed by The Official Committee of Unsecured Creditors (Klein, Julia)
Response Genetics, Inc. (f/d/b/a Bio Type, Inc.) filed for bankruptcy protection, or had an involuntary bankruptcy petition filed against it, on August 9, 2015. The bankruptcy case is pending before the United States Bankruptcy Court for the District of Delaware. The case number for the lead bankruptcy case is 15-11663. The bankruptcy case is currently assigned to United States Bankruptcy Judge Laurie Selber Silverstein. The law firm of Pachulski Stang Ziehl & Jones LLP is acting as lead bankruptcy counsel to Response Genetics, Inc. (f/d/b/a Bio Type, Inc.) in the bankruptcy case.